Education

During a visit to Milwaukee, Gov. Jim Doyle announced state investment commitments of $12.5 million for the Medical College of Wisconsin, and $3.5 million for the University of Wisconsin-Milwaukee. The investments are designed to boost healthcare collaboration and services, and the training of engineers in...

The decision by NimbleGen Systems to file for an initial public offering may primarily be an exit strategy for its investors, but it's also the latest piece of a global sales strategy. Company officials have been mum on recent fund-raising developments, but they have also...

Attorney David Kettner has decided to leave the Wisconsin Alumni Research Foundation and join the staff of Virent Energy Systems as chief intellectual property counsel. During his career, Kettner has emphasized biotech patent prosecution and intellectual property licensing....

Taking learning beyond the classroom and computer desk, Sonic Foundry has introduced new podcasting and automated scheduling capabilities for its Mediasite communications product. The updated version of Mediasite promises enhanced workflow for the increasingly popular podcast communications channel....

Instructors at Madison Area Technical College would like to see more women going into information technology careers. The percentage of women preparing for IT careers at MATC has dropped below 20 percent, but the college is trying to change that with a series of programs...

Leroy Hood, who this spring will be inducted into the National Inventor's Hall of Fame, has joined the board of directors of NimbleGen Systems, a Madison biotechnology firm. Hood, who gained fame by creating a DNA sequencer to map the human genome, will serve as...

Even though the State of Wisconsin supports the UW System, most of the “technology transfer” in Wisconsin gets done without direct state funding, notes Inside Wisconsin columnist Tom Still. Despite this lack of state support, UW-Madison and WARF rank near the top in terms of...

Deltanoid Pharmaceuticals will continue its development of a novel compound to reverse bone loss caused by osteoporosis. The company has initiated Phase II clinical studies to determine whether the compound, known as SMD, can improve mineral bone density in postmenopausal women. The global market for...